ArticleRSC advances2025
Enhanced separation of europium radionuclides from active solutions using a novel sorbent of gadolinium metal-organic framework.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Preserving environmental quality when disposing of hazardous waste, especially radioactive waste, is a relevant research area that attracts the interest of global scientists. The separation of harmful species on the surface of novel adsorbent metal-organic frameworks (MOFs) is a promising and effective method for achieving this goal. This study identifies a new metal-organic framework known as melamine-terephthalic acid (MTGd MOF) that was synthesized and then treated with oxalic acid to produce modified MTGd-OX MOF that has been characterized. The MOFs were formed successfully based on the characterization results. BET results show that MTGd MOF and MTGd-OX MOF have surface areas of 1857.40 and 1955.16 m
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.